Conversion of Urine Protein–Creatinine Ratio or Urine Dipstick Protein to Urine Albumin–Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis
posted on 2020-07-22, 15:14authored byKeiichi Sumida, Girish N Nadkarni, Morgan E Grams, Yingying Sang, Shoshana H Ballew, Josef Coresh, Kunihiro Matsushita, Aditya Surapaneni, Nigel Brunskill, Steve J Chadban, Alex R Chang, Massimo Cirillo, Kenn B Daratha, Ron T Gansevoort, Amit X Garg, Licia Iacoviello, Takamasa Kayama, Tsuneo Konta, Csaba P Kovesdy, James Lash, Brian J Lee, Rupert W Major, Marie Metzger, Katsuyuki Miura, David MJ Naimark, Robert G Nelson, Simon Sawhney, Nikita Stempniewicz, Mila Tang, Raymond R Townsend, Jamie P Traynor, José M Valdivielso, Jack Wetzels, Kevan R Polkinghorne, Hiddo JL Heerspink
<div>Background: Although measuring albuminuria is the preferred method for defining and staging chronic kidney disease (CKD), total urine protein or dipstick protein is often measured instead.</div><div><br></div><div>Objective: To develop equations for converting urine protein creatinine ratio (PCR) and dipstick protein to urine albumin creatinine ratio (ACR) and to test their diagnostic accuracy in CKD screening and staging.</div><div><br></div><div>Design: Individual participant–based meta-analysis.</div><div><br></div><div>Setting: 12 research and 21 clinical cohorts.</div><div><br></div><div>Participants: 919 383 adults with same-day measures of ACR and PCR or dipstick protein.</div><div><br></div><div>Measurements: Equations to convert urine PCR and dipstick protein to ACR were developed and tested for purposes of CKD screening (ACR ≥30 mg/g) and staging (stage A2: ACR of 30 to 299 mg/g; stage A3: ACR ≥300 mg/g).</div><div><br></div><div>Results: Median ACR was 14 mg/g (25th to 75th percentile of cohorts, 5 to 25 mg/g). The association between PCR and ACR was inconsistent for PCR values less than 50 mg/g. For higher PCR values, the PCR conversion equations demonstrated moderate sensitivity (91%, 75%, and 87%) and specificity (87%, 89%, and 98%) for screening (ACR >30 mg/g) and classification into stages A2 and A3, respectively. Urine dipstick categories of trace or greater, trace to +, and ++ for screening for ACR values greater than 30 mg/g and classification into stages A2 and A3, respectively, had moderate sensitivity (62%, 36%, and 78%) and high specificity (88%, 88%, and 98%). For individual risk prediction, the estimated 2-year 4-variable kidney failure risk equation using predicted ACR from PCR had discrimination similar to that of using observed ACR.</div><div><br></div><div>Limitation: Diverse methods of ACR and PCR quantification were used; measurements were not always performed in the same urine sample.</div><div><br></div><div>Conclusion: Urine ACR is the preferred measure of albuminuria; however, if ACR is not available, predicted ACR from PCR or urine dipstick protein may help in CKD screening, staging, and prognosis.</div>
Funding
National Institute of Diabetes and Digestive and Kidney Diseases and National Kidney Foundation.
History
Citation
Annals of Internal Medicine, 2020, https://doi.org/10.7326/M20-0529
Author affiliation
Department of Health Sciences, University of Leicester